Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
+1.14M
-
Total reported value, excl. options
-
$299M
-
Value change
-
+$9.01M
-
Number of buys
-
44
-
Number of sells
-
-27
-
Price
-
$13.48
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2016
85 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q3 2016.
Editas Medicine, Inc. - Common Stock (EDIT) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 82.8M outstanding shares and own 26.84% of the company stock.
Largest 10 shareholders include FMR LLC (5.49M shares), Polaris Venture Management Co. VI, L.L.C. (4.16M shares), Flagship Ventures Management, Inc. (3.46M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.87M shares), Viking Global Investors LP (1.71M shares), DEERFIELD MANAGEMENT CO (1.71M shares), VANGUARD GROUP INC (1.25M shares), Capital World Investors (295K shares), MORGAN STANLEY (252K shares), and BlackRock Fund Advisors (177K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.